ERBB2 and breast carcinoma: For example, S63845 improves the response of the BT-474 HER2-amplified breast cancer cell line to lapatinib (HER2 tyrosine kinase inhibitor) in 2-D cell culture, and also inhibits growth of TNBC PDX cells in 3-D tumoursphere assays [110,117].